USPTO serial 79439990
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura Schneider
Laura Schneider ROGUE.LAW446 E 29th St #1689Loveland, CO 80538United States| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Beds, bedding, namely, fitted sheets, draw sheets and slide sheets for beds for medical use, and sleep equipment, namely, medical devices for treating sleep disorders, all for medical and healthcare purposes; beds for medical use, bedding, namely, fitted sheets, draw sheets and slide sheets for beds for medical use, and equipment, namely, medical devices for treating sleep disorders, for moving and repositioning patients; beds for medical use, bedding, namely, fitted sheets, draw sheets and slide sheets for beds for medical use, and equipment, namely, medical devices for treating sleep disorders, for improving sleep position in patients; beds for medical use, bedding, namely, fitted sheets, draw sheets and slide sheets for beds for medical use, and equipment, namely, medical devices for treating sleep disorders, for enhancing the sleep quality of patients; smart beds, bedding, namely, fitted sheets, draw sheets and slide sheets for beds for medical use, and sleep equipment, namely, medical devices for treating sleep disorders, all for medical and healthcare purposes. | ACTIVE | — |
| 044 | Consultancy, advisory, and information services relating to medical equipment, namely, beds, bedding, and sleep equipment, all for medical and healthcare purposes. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 1, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 1, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 5, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 5, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 8, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 7, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 31, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 31, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 25, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |